2021
DOI: 10.1007/s11883-021-00956-x
|View full text |Cite
|
Sign up to set email alerts
|

Managing Ischemic Heart Disease in Women: Role of a Women’s Heart Center

Abstract: Purpose of Review Heart centers for women (HCW) were developed due to the rising cardiovascular morbidity and mortality in women in the United States in the early 1990s. Our review encompasses the epidemiology, risk factors, diagnostic strategies, treatments, and the role of HCW in managing women with ischemic heart disease (IHD). Recent Findings HCW use a multidisciplinary team to manage women with IHD. Due to the paucity of randomized controlled trials investigating v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 118 publications
0
15
0
3
Order By: Relevance
“…Ischaemic heart disease (IHD), manifested as a myocardial infarction (MI), represents the leading cause of death in women [ 124 ]. In patients under the age of 55, the association of hypertension, depression, diabetes, current smoking, a family history of diabetes, and younger age is stronger for MI in women than men [ 125 ].…”
Section: Sex Dimorphism and Obesity-related Cardiovascular Abnormalitiesmentioning
confidence: 99%
“…Ischaemic heart disease (IHD), manifested as a myocardial infarction (MI), represents the leading cause of death in women [ 124 ]. In patients under the age of 55, the association of hypertension, depression, diabetes, current smoking, a family history of diabetes, and younger age is stronger for MI in women than men [ 125 ].…”
Section: Sex Dimorphism and Obesity-related Cardiovascular Abnormalitiesmentioning
confidence: 99%
“… 38 , 39 This level of non-persistence is problematic as pharmacological treatment reduces risk of MACE, also in females who more often suffer from a non-obstructive coronary artery disease that causes a different ischemic endothelial damage profile compared to men. 16 …”
Section: Discussionmentioning
confidence: 99%
“… 14 , 15 Further, any delay in secondary pharmacological treatment will increase risk of MACE, also in females who more often suffer from non-obstructive coronary artery disease. 16 …”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4] This phenomenon has come to be known as the "gender paradox" and may lead to misdiagnosis and poorer outcome in women. [5][6][7] Importantly, in both women and men, coronary artery disease accounts for a similar and high proportion of all cause death in western doi: 10.1136/bmj-2022-071133 | BMJ 2022;379:e071133 | the bmj countries. [8][9][10] Nevertheless, the paucity of diagnostic and management trials specifically randomising either women or men and predefining such subgroups as targets for analysis in terms of outcomes precludes informed clinical recommendations.…”
Section: Introductionmentioning
confidence: 99%